News Focus
News Focus
icon url

faraifarai

01/08/15 9:43 AM

#85492 RE: BioHedge #85491

Completely agree.
icon url

scottsmith

01/08/15 9:49 AM

#85493 RE: BioHedge #85491

I think we all need to calm down about the lack of PR. For two reasons: 1) if the drug works, price will eventually take care of itself and 2) all these articles people have posted to are raising general awareness; while not specifically directed at B, they are planting the seed in people's minds. This will pay off when B is fully introduced.
icon url

slcimmuno

01/08/15 10:04 AM

#85497 RE: BioHedge #85491

Must say that is a bit of my concern too
Though IHUBers efforts can help get message out virally, CTIX is small and stretched. IMO it'll take some real PR heft (plus landing in clinical journals), to prob make the kind of splash we know the story deserves. Seems some are planning to gameplan next week Cali during the conference. Perhaps those with access to Leo can whisper ideas into his ear.

Here's a comparison on Datpomyicin, its story retold--and the piece is even creatively titled: Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD
http://cid.oxfordjournals.org/content/50/Supplement_1/S10.full

Note that ApotheCom Assocates helped tell the tale.
http://www.apothecom.com/

Its pitch:

A Global Agency Powerhouse

Apothecom, a member of Huntsworth Health, is one of the top medical communications agencies in the world. Our clients include some of the most successful pharma and biotech brands. Our passion is creating and communicating the scientific story across the right platforms for our clients’ brands.
icon url

centillion

01/08/15 10:18 AM

#85502 RE: BioHedge #85491

Just watched a quick clip of that discovery on ABC Good Morning America, 7:16 am PT. A pre-clinical drug?
Shake of the head!
icon url

BIzzy

01/08/15 10:33 AM

#85506 RE: BioHedge #85491

I could not agree more...the fact that ten posters are posting comments all over the media is wonderful..the fact that these same posters are not driving a unified message is bad..the most glaring example is waffling on the resistance issue with B..using the right language is critical....the difference between using the word "may"and "shall" in statutory legislation is huge..just as "there is no resistance to T" is much different than "we think there will be no resistance to B" is not how it ought to be framed

All this grass roots messaging for B is better served as support to someone who actually knows what the hell they are doing..if you dont own the message and set the narrative things can get much worse than a over hyped article about T..how about some asshole setting the narrative about B for us...like Cramers crew

Tesla versus Edison....absolutely correct